| Cat. No. |
Size |
Price |
Figures |
|---|
RP10457-5 mg
| 5 mg | $ 38.00 | MSDS: 20080728034953 (PDF)
References:
- Grace RC, et al. Solution structure of the tachykinin peptide eledoisin. Biophys J. Jan 2003; 84(1): 655-664.
- Vickers C, et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem. Apr 2002; 277(17): 14838-14843.
- Severini C, et al. The tachykinin peptide family. Pharmacol Rev. Jun 2002; 54(2): 285-322.
|
|---|
| Full Name | | Eledoisin Related Peptide |
|
| Alias |
ERP |
Sequence
(one-letter code) |
KFIGLM-NH2 |
Sequence
(three-letter code) | {LYS}{PHE}{ILE}{GLY}{LEU}{MET}-NH2 |
|---|
| C-Terminal | NH2 |
|---|
| Description | Eledoisin Related Peptide is a tachykinin receptor ligand and analogue of substance P. ERP can increase spontaneous activity and depolarizing neurons by decreasing membrane conductance. |
|---|
| Solubility | Soluble in water. The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weight out a smaller portion of the contents. |
|---|
| Formula | C34H58N8O6S1 |
|---|
| M.W. | 706.94 |
|---|
| Purity | > 95% |
|---|
| Storage | Storage at -20°C. Keep tightly closed. |
| Notes | Eledoisin Related Peptide is a tachykinin receptor ligand and analogue of substance P.
|
|---|
